摘要
背景:心力衰竭患者(HF)的肾功能显著下降。我们调查了心衰患者肾功能不全的新标志物和炎症状态和心肌重构指数之间的相关性。 方法:参考年龄和性别,我们招募了79名持续心力衰竭患者和79名健康受试者。 用ELISA法测定中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、半胱氨酸蛋白酶抑制剂C、B型利钠肽(BNP)、肿瘤坏死因子α(TNFα)和基质金属蛋白酶9(MMP-9)在血清的水平。使用克罗夫特-高特公式(eCcl)估计肌酐清除率。 左心室射血率是由超声心动图决定。结果: 与健康受试者相比,心力衰竭的患者有明显更高的NGAL (p=0.007) 和半胱氨酸蛋白酶抑制物c水平 (p=0.005)。 在心力衰竭患者中,NGAL水平和肌酐水平,(r=0.40, p<0.001)、 TNFα水平 (r=0.43, p<0.001),、BNP 水平 (r=0.36, p=0.003)、MMP-9 水平 (r=0.37, p=0.02)呈正相关,并且NGAL水平与左心室射血率负相关 (r=-0.23, p=0.045)。有趣的是,NGAL和MMP-9水平之间的关系不受其它因素如年龄、性别、体重指数、左心室射血率、 TNFα 水平和 BNP 水平的影响。此外,心力衰竭患者的半胱氨酸蛋白酶抑制物c水平和eCcl呈负相关(r=-0.21, p=0.04)、 半胱氨酸蛋白酶抑制物c水平与 TNFa、 BNP、MMP-9 水平和及左心室射血率无关(所有因素的p=NS)。结论: NGAL与左心室射血率,心力衰竭患者的心脏重塑和炎症生物标记有关。 这些发现注重反映了在心力衰竭患者中可能常见的肾脏功能障碍发病的机制、发炎过程和心脏功能障碍。
关键词: 生物标志物,心脏重塑,半胱氨酸蛋白酶抑制剂C,心力衰竭,炎症,中性粒细胞明胶酶相关脂质运载蛋白, 肾功能.
Current Medicinal Chemistry
Title:Novel Biomarkers Assessing Renal Function in Heart Failure: Relation to Inflammatory Status and Cardiac Remodelling
Volume: 21 Issue: 34
Author(s): Gerasimos Siasos, Dimitris Tousoulis, Stavroula Michalea, Evangelos Oikonomou, Manolis Vavuranakis, Dimitris Athanasiou, Panagiotis Tourikis, Nikolaos Gouliopoulos, Antigoni Miliou, Konstantinos Mourouzis, Maria Limperi, Savvas Mazaris, Athanasios G Papavassiliou and Christodoulos Stefanadis
Affiliation:
关键词: 生物标志物,心脏重塑,半胱氨酸蛋白酶抑制剂C,心力衰竭,炎症,中性粒细胞明胶酶相关脂质运载蛋白, 肾功能.
摘要: Background: Patients with heart failure (HF) have a significant decline of renal function. We investigate the association between novel biomarkers of renal dysfunction and indices of inflammatory status and cardiac remodeling in patients with HF. Methods: We enrolled 79 consecutive patients with HF and 79 healthy subjects, adjusted for age and sex. Serum levels of neutrophil gelatinase-associated lipocalin (NGAL), cystatin-C, b-type natriuretic peptide (BNP), tumor necrosis factor alpha (TNFα) and matrix metalloproteinase-9 (MMP-9) were measured by ELISA. Creatinine clearance was estimated using Cockcroft-Gault formula (eCcl). Left ventricular ejection fraction was determined by echocardiography. Results: Patients with HF, compared to healthy subjects, had significantly higher NGAL (p=0.007) and cystatin-C levels (p=0.005). In HF patients, NGAL levels were positively correlated with Creatinine levels (r=0.40, p<0.001), TNFa levels (r=0.43, p<0.001), BNP levels (r=0.36, p=0.003), MMP-9 levels (r=0.37, p=0.02) and inversely correlated with left ventricle ejection fraction (r=-0.23, p=0.045). Interestingly, the association between NGAL and MMP-9 levels was independent from confounders such as age, gender, left ventricle ejection fraction, body mass index, TNFα levels, and BNP levels. Moreover, in HF patients, cystatin-C levels were inversely correlated with eCcl (r=-0.21, p=0.04). Cystatin-C levels were not correlated with TNFa, BNP, MMP-9 levels and with left ventricle ejection fraction (p=NS for all). Conclusions: NGAL is associated with left ventricle ejection fraction, and biomarkers of inflammation and cardiac remodeling in patients with HF. These findings highlight a possible common pathogenetic mechanism of renal dysfunction, inflammatory process and cardiac dysfunction in HF.
Export Options
About this article
Cite this article as:
Siasos Gerasimos, Tousoulis Dimitris, Michalea Stavroula, Oikonomou Evangelos, Vavuranakis Manolis, Athanasiou Dimitris, Tourikis Panagiotis, Gouliopoulos Nikolaos, Miliou Antigoni, Mourouzis Konstantinos, Limperi Maria, Mazaris Savvas, Papavassiliou G Athanasios and Stefanadis Christodoulos, Novel Biomarkers Assessing Renal Function in Heart Failure: Relation to Inflammatory Status and Cardiac Remodelling, Current Medicinal Chemistry 2014; 21 (34) . https://dx.doi.org/10.2174/0929867321666140826114656
DOI https://dx.doi.org/10.2174/0929867321666140826114656 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bioavailability of Quercetin: Problems and Promises
Current Medicinal Chemistry Vitamin D and Physical Performance in Athletes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Plasma and Tissue Kininogen-kallikrein-kinin System: Role in the Cardiovascular System
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Anti-Inflammatory and Anti-Neoplastic Actions of Resveratrol
Current Nutrition & Food Science ACE Inhibition of Plant Alkaloids Targeted Approach for Selective Inhibition
Mini-Reviews in Organic Chemistry Nanotechnological Strategies for the Treatment of Neglected Diseases
Current Pharmaceutical Design Advances in Peptide Pharmaceuticals
Current Pharmaceutical Biotechnology Treatment of Epileptic Encephalopathies
Current Pharmaceutical Design Cancer Stem Cells and their Management in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Sodium-glucose Cotransporter 2 Inhibitors: The Impact on Development and Progression of Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Trends in Mitochondrial Therapeutics for Neurological Disease
Current Medicinal Chemistry Stenting and Prevention of Ischemic Stroke
Current Drug Targets The Cannabinoids Switch of Oxidative Stress: A Double-Edged Sword
Mini-Reviews in Organic Chemistry Class III Antiarrhythmics and Phenytoin: Teratogenicity Due to Embryonic Cardiac Dysrhythmia and Reoxygenation Damage
Current Pharmaceutical Design Circulating Biomarkers of Collagen Metabolism and Prognosis of Heart Failure with Reduced or Mid-Range Ejection Fraction
Current Pharmaceutical Design Inverse Regulation of MMP-9 and MMP-2 in Long-Term Follow-up After Acute Coronary Syndrome: Lack of Correlation with Platelet and Endothelial Cell Activation Markers
Vascular Disease Prevention (Discontinued) Patent Selections
Recent Patents on Cardiovascular Drug Discovery “Cardiovascular” Drugs in Rheumatoid Arthritis: Killing Two Birds with One Stone?
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Leishmaniasis: Current Treatment and Prospects for New Drugs and Vaccines
Current Medicinal Chemistry Farnesoid-X Receptor (FXR) as a Promising Pharmaceutical Target in Atherosclerosis
Current Medicinal Chemistry